Back

The LDL-C/Apo B ratio predicts mortality in heart failure patients both with and without type 2 diabetes

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes and mortality in heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speakers

Photo
Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

Photo
Doctor Barbara Larcher

0012o00003HdGn8AAF (VIVIT), Feldkirch (Austria)

6 More presentations in this session

Presentation thumbnail
Exercise-induced disproportionate secondary mitral regurgitation is associated with poor outcome in heart failure patients
Doctor P. Leuders (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Evolving trends in pulmonary hypertension and mortality in heart failure
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Identifying high-risk patients using artificial intelligence-enabled electrocardiogram: early detection of rehospitalization in post-discharge heart failure patients
Ms S. Kang (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Comparison of plasma cardiovascular biomarker levels in acute heart failure between Europe and Japan
Doctor J. Bruno (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Evaluating the prognostic value of left ventricular outflow tract velocity time integral (LVOT VTI) in LV dysfunction: Insights from the National Echocardiographic Database of Australia (NEDA).
Doctor J. Eng-Frost (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes and mortality in heart failure

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of excess apolipoprotein B in coronayr artery disease: a pooled analysis of nationwide cohorts
thumbnail
Congress Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count
thumbnail
Congress Presentation
Lipid risk profile in elderly patients with AHF and long-term follow-up

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources